![Sheri Strangway](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sheri Strangway
Corporate Officer/Principal en Thread Fx, Inc. .
Origen de la red de primer grado Sheri Strangway.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Active With Me, Inc.
![]() Active With Me, Inc. Miscellaneous Commercial ServicesCommercial Services Active With Me, Inc. provides online resources that seamlessly offer travelers unique, highly relevant and user-friendly information on activity-based travel. Its listings will be provided for product and service providers of interest to the activity-based traveler. The company was founded on December 6, 2012 and is headquartered in Sarnia, Canada.
7
| Extinct | Miscellaneous Commercial Services | 7 |
Thread Fx, Inc.
1
| Private Company | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sheri Strangway a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Chief Executive Officer Chairman | |
Tiziana Life Sciences Ltd. (United Kingdom)
![]() Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer | |
SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
OKYO PHARMA LIMITED | Biotechnology | Director/Board Member Director/Board Member | |
TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Sophocles Group LLC
![]() The Sophocles Group LLC Financial ConglomeratesFinance The Sophocles Group LLC provides investment services. The private company is based in Princeton. | Financial Conglomerates | Corporate Officer/Principal | |
Sanguine BioSciences, Inc.
![]() Sanguine BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services Sanguine BioSciences, Inc. provides biomedical research services and develops drugs. The firm maintains a bio repository of frozen samples from donors in various disease indications such as PBMC, PBMC subtypes, plasma, serum, cerebral spinal fluid, blood units and DNA/RNA. The company was founded by Brian Neman and Gerald H. Lee in 2010 and is headquartered in Sherman Oaks, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Bioscience Strategies NZ Ltd. | Chief Executive Officer | ||
Affectis Pharmaceuticals AG
![]() Affectis Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Affectis Pharmaceuticals AG discovers and develops drugs for the treatment of neurodegenerative and neuroinflammatory diseases. Its products in pipeline include AFC-5128, P2X7 Compounds, AFC-5278 and AFC-08. The company was founded in January 2004 by Florian Holsboer, Wolfgang Wurst and Herbert Stadler and is headquartered in Dortmund, Germany. | Pharmaceuticals: Major | President | |
moksha8 Pharmaceuticals, Inc.
![]() moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin | |
Engender Technologies Ltd.
![]() Engender Technologies Ltd. Medical/Nursing ServicesHealth Services Engender Technologies Ltd. engages in the research and development of gender selection especially in the dairy industry. The company was founded by Miriam Cather Simpson on October 6, 2011 and is headquartered in Auckland, New Zealand. | Medical/Nursing Services | Director/Board Member | |
Realm Therapeutics, Inc. | Chief Executive Officer | ||
Veralox Therapeutics, Inc.
![]() Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Pharmaceuticals: Major | Chairman | |
Smithkline Beecham Pharmaceuticals (Canada) | Corporate Officer/Principal | ||
The University of Exeter | College/University | Doctorate Degree | |
Exosomics SpA
![]() Exosomics SpA Medical SpecialtiesHealth Technology Exosomics SpA is an Italian company that manufactures pre-analytical products to isolate nucleic acids from tumor derived extracellular vesicles. The private company is based in Siena, Italy. The company was founded by Antonio Chiesi. Antonio Chiesi has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Externautics SpA
![]() Externautics SpA BiotechnologyHealth Technology Externautics SpA provides biotechnology research and development services. The firms designs and manages platforms that identify and develop novel diagnostic and therapeutic markers for oncology applications. Its technology approach is based on the screening of libraries of polyclonal antibodies and recombinant proteins, generated from the corresponding human gene library of the poorly known membrane and secreted proteins. It focuses on the identification of membrane-exposed or serum circulating proteins whose presence associate to the frequent types of human tumors. The company was founded by Guido Grandi in 2007 and is headquartered in Siena, Italy. | Biotechnology | Director/Board Member | |
TES Pharma SRL
![]() TES Pharma SRL Medical SpecialtiesHealth Technology TES Pharma SRL provides vitro diagnostics. The private company is based in Corciano, Italy. The Italian company was founded in 2011 by Roberto Pellicciari. Roberto Pellicciari has been the CEO since 2011. | Medical Specialties | Director/Board Member | |
IRBM Science Park SpA
![]() IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services IRBM Science Park SpA engages in researching and developing biomedical products. The company is headquartered in Pomezia, Italy. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Fondazione Ri.MED
![]() Fondazione Ri.MED Miscellaneous Commercial ServicesCommercial Services Fondazione Ri.MED leads biomedical and biotechnological research projects. The non-profit company is based in Palermo, Italy. Alessandro Padova has been the CEO of the Italian company since 2015. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Kent | College/University | Undergraduate Degree | |
ESSA PHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
TNA Therapeutics, Inc. | Chief Executive Officer | ||
REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Abcuro, Inc.
![]() Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Fordham University School of Law | College/University | Graduate Degree | |
Palladio Biosciences, Inc.
![]() Palladio Biosciences, Inc. BiotechnologyHealth Technology Palladio Biosciences, Inc. develops transformative medicines for orphan diseases. Its pipeline includes Lixivaptan, a selective vasopressin V2 receptor antagonist for the treatment of polycystic kidney disease, a life-threatening genetic disease. The company was founded by Lorenzo Pellegrini in 2015 and is headquartered in Newtown, PA. | Biotechnology | Chief Executive Officer | |
PolyBatics Ltd.
![]() PolyBatics Ltd. Miscellaneous Commercial ServicesCommercial Services PolyBatics Ltd. engages in the design, development, manufacturing and marketing of bionanoparticles. Its products include Assign-bTB, PolyZyme-CALB, PolyBind-Z and PolyBind-G. The firm harnesses the natural power of cells to create natural polymer particles, or biobeads, covered with proteins engineered to perform specific functions. The comapny was founded by Tracy Thompson and Bernd H. A. Rehm on January 9, 2009 and is headquartered in Palmerston North, New Zealand. | Miscellaneous Commercial Services | Director/Board Member | |
Tamir Biotechnology, Inc.
![]() Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Director/Board Member | |
Apple Tree venture Managemnet Llc//vc
![]() Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Corporate Officer/Principal | |
Arna Therapeutics Ltd.
![]() Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Miscellaneous Commercial Services | Director/Board Member | |
CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
Seton Hall University | College/University | Undergraduate Degree | |
FermaVir Pharmaceuticals LLC
![]() FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member | |
ELINE ENTERTAINMEN | Movies/Entertainment | Director of Finance/CFO | |
Memory Pharmaceuticals Corp.
![]() Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Director of Finance/CFO |
Estadísticas
Internacional
Estados Unidos | 30 |
Italia | 8 |
Reino Unido | 5 |
Nueva Zelanda | 4 |
Bermudas | 3 |
Sectorial
Health Technology | 28 |
Consumer Services | 8 |
Commercial Services | 7 |
Finance | 3 |
Distribution Services | 2 |
Operativa
Director/Board Member | 50 |
Corporate Officer/Principal | 24 |
Independent Dir/Board Member | 14 |
Chief Executive Officer | 13 |
Chairman | 8 |
Las relaciones más conectadas
Insiders | |
---|---|
Alex Martin Martin | 19 |
John Brancaccio | 18 |
Riccardo Dalla-Favera | 18 |
James Mervis | 15 |
Kunwar Shailubhai | 14 |
Alessandro Padova | 10 |
Jim Tripp | 7 |
Doug Small | 2 |
- Bolsa de valores
- Insiders
- Sheri Strangway
- Conexiones Empresas